These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 15715685

  • 1. Nt-proANP in plasma, a marker of salt sensitivity, is reduced in type 2 diabetes patients.
    Melander O, Frandsen E, Magnusson M, Grubb A, Jovinge S, Groop L.
    J Intern Med; 2005 Mar; 257(3):281-8. PubMed ID: 15715685
    [Abstract] [Full Text] [Related]

  • 2. Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide.
    Jarai R, Iordanova N, Jarai R, Raffetseder A, Woloszczuk W, Gyöngyösi M, Geyer G, Wojta J, Huber K.
    Eur Heart J; 2005 Feb; 26(3):250-6. PubMed ID: 15618049
    [Abstract] [Full Text] [Related]

  • 3. Moderate salt restriction effectively lowers blood pressure and degree of salt sensitivity is related to baseline concentration of renin and N-terminal atrial natriuretic peptide in plasma.
    Melander O, von Wowern F, Frandsen E, Burri P, Willsteen G, Aurell M, Hulthén UL.
    J Hypertens; 2007 Mar; 25(3):619-27. PubMed ID: 17278979
    [Abstract] [Full Text] [Related]

  • 4. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
    Elmas E, Brueckmann M, Lang S, Kälsch T, Haghi D, Sueselbeck T, Dempfle CE, Borggrefe M.
    Int J Cardiol; 2008 Aug 18; 128(2):244-9. PubMed ID: 17673312
    [Abstract] [Full Text] [Related]

  • 5. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.
    J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563
    [Abstract] [Full Text] [Related]

  • 6. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients.
    Hoffmann U, Brueckmann M, Bertsch T, Wiessner M, Liebetrau C, Lang S, Haase KK, Borggrefe M, Huhle G.
    Clin Lab; 2005 Nov 13; 51(7-8):373-9. PubMed ID: 16122147
    [Abstract] [Full Text] [Related]

  • 7. [Personal experience with determination of NT-proBNP in clinical practice].
    Stejskal D, Oral I, Lacnák B, Juráková R, Horalík D, Adamovská S, Prosková J, Hrabovská I, Ozanová G.
    Vnitr Lek; 2003 Feb 13; 49(2):121-6. PubMed ID: 12728579
    [Abstract] [Full Text] [Related]

  • 8. ProANP and NT-proBNP levels to prospectively assess cardiac function in breast cancer patients treated with cardiotoxic chemotherapy.
    Kouloubinis A, Kaklamanis L, Ziras N, Sofroniadou S, Makaritsis K, Adamopoulos S, Revela I, Athanasiou A, Mavroudis D, Georgoulias V.
    Int J Cardiol; 2007 Nov 30; 122(3):195-201. PubMed ID: 17289172
    [Abstract] [Full Text] [Related]

  • 9. NT-proBNP in normoalbuminuric patients with Type 2 diabetes mellitus.
    Andersen NH, Poulsen SH, Knudsen ST, Heickendorff L, Mogensen CE.
    Diabet Med; 2005 Feb 30; 22(2):188-95. PubMed ID: 15660737
    [Abstract] [Full Text] [Related]

  • 10. Natriuretic peptides in patients with aortic stenosis.
    Qi W, Mathisen P, Kjekshus J, Simonsen S, Bjørnerheim R, Endresen K, Hall C.
    Am Heart J; 2001 Oct 30; 142(4):725-32. PubMed ID: 11579366
    [Abstract] [Full Text] [Related]

  • 11. Plasma concentrations of natriuretic peptides in normal cats and normotensive and hypertensive cats with chronic kidney disease.
    Lalor SM, Connolly DJ, Elliott J, Syme HM.
    J Vet Cardiol; 2009 May 30; 11 Suppl 1():S71-9. PubMed ID: 19398225
    [Abstract] [Full Text] [Related]

  • 12. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D, Matias JS, Sargento L, Cabral MJ, Madeira HC.
    Rev Port Cardiol; 2004 Dec 30; 23(12):1557-82. PubMed ID: 15732658
    [Abstract] [Full Text] [Related]

  • 13. Prognostic merit of N-terminal-proBNP and N-terminal-proANP in mechanically ventilated critically ill patients.
    Berdal JE, Stavem K, Omland T, Hall C, Smith-Erichssen N.
    Acta Anaesthesiol Scand; 2008 Oct 30; 52(9):1265-72. PubMed ID: 18823467
    [Abstract] [Full Text] [Related]

  • 14. Natriuretic peptides and hemodynamics in preeclampsia.
    Tihtonen KM, Kööbi T, Vuolteenaho O, Huhtala HS, Uotila JT.
    Am J Obstet Gynecol; 2007 Apr 30; 196(4):328.e1-7. PubMed ID: 17403408
    [Abstract] [Full Text] [Related]

  • 15. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
    Moertl D, Berger R, Struck J, Gleiss A, Hammer A, Morgenthaler NG, Bergmann A, Huelsmann M, Pacher R.
    J Am Coll Cardiol; 2009 May 12; 53(19):1783-90. PubMed ID: 19422985
    [Abstract] [Full Text] [Related]

  • 16. High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock.
    Vergès B, Zeller M, Desgrès J, Dentan G, Laurent Y, Janin-Manificat L, L'Huillier I, Rioufol G, Beer JC, Makki H, Rochette L, Gambert P, Cottin Y.
    Eur Heart J; 2005 Sep 12; 26(17):1734-41. PubMed ID: 15831555
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.